Pilot tolerability studies of hydroxychloroquine and colchicine in Alzheimer disease

Alzheimer Disease and Associated Disorders

Volumn 15, Issue 2, 2001, Pages 96-101

  Aisen, Paul S ^a,b   Marin, Deborah B ^a   Brickman, Adam M ^a   Santoro, Jennifer ^a   Fusco, Maureen ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Clinical trial; Colchicine; Hydroxychloroquine; Inflammation

Indexed keywords

COLCHICINE; HYDROXYCHLOROQUINE;

ADULT; AGED; ALZHEIMER DISEASE; BEHAVIOR; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL;

AGED; ALZHEIMER DISEASE; COLCHICINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEASIBILITY STUDIES; FEMALE; HUMANS; HYDROXYCHLOROQUINE; MALE; MIDDLE AGED; PILOT PROJECTS;

EID: 0034995528     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002093-200104000-00009     Document Type: Conference Paper

References (45)

1. Anti-inflammatory therapy for Alzheimer's disease: A status report
2. Inflammatory mechanisms in Alzheimer's disease: Implications for therapy
3. A pilot study of colchicine in Alzheimer's disease
4. Hydroxychloroquine sulfate in rheumatoid arthritis: Long term response rate and predictive parameters
5. 3H]colchicine into brain and liver of mouse, rat, and chick
6. Studies on the chemotherapy of the human malarias. VI. The physiological disposition, antimalarial activity, and toxicity of several derivatives of 4-amino quinoline
7. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects
8. Chloroquine inhibits intracellular degradation but not secretion of Alzheimer β/A4 amyloid precursor protein
9. Colchicine
10. Lysosomotropic agents
11. Role of P-170 glycoprotein in colchicine brain uptake
12. Regression of reactive systemic amyloidosis due to ankylosing spondylitis following the administration of colchicine
13. Simultaneous microdialysis in brain and blood of the mouse: Extracellular and intracellular brain colchicine disposition
14. The mini-mental state examination
15. Inhibition of mononuclear phagocytes reduces ischemic injury in the spinal cord
16. Processing of the amyloid precursor for potentially amyloidogenic derivatives
17. Interleukin-1 regulates synthesis of amyloid beta protein precursor mRNA in human endothelial cell
18. Role of microtubuli in lysosomal protein degradation
19. Cerebral blood flow in dementia
20. A rating scale for depression
21. A randomized trial of hydroxychloroquine in early rheumatoid arthritis: The HERA study
22. Protective effect of a low dose of colchicine on the delayed cell death of hippocampal CA1 neurons following transient forebrain ischemia
23. Kinetics of amyloid deposition. II. The effects of dimethylsulfoxide and colchicine therapy
24. Inhibition of LPS-induced tumor necrosis factor-alpha production by colchicine and other microtubule disrupting drugs
25. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: A review of 17 epidemiologic studies
26. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group
27. The Alzheimer's Disease Assessment Scale (ADAS): An instrument for assessing treatment efficacy
28. Plaquenil in the treatment of lupus erythematosus
29. Neurotoxic effects of colchicine
30. Brief psychiatric rating scale
31. Chloroquine myopathy suggests that tau is degraded in lysosomes: Implication for the formation of paired helical filaments in Alzheimer's disease
32. Colchicine effects on lysosomal enzyme induction and intracellular degradation in the cultivated macrophage
33. Colchicine inhibits arachidonate release and 5-lipoxygenase action in alveolar macrophages
34. Neuroprotective effects of colchicine in the gerbil model of cerebral ischemia
35. Evidence that secretase cleavage of cell surface Alzheimer amyloid precursor occurs after normal endocytotic internalization
36. Colchicine inhibits ionophore-induced formation of leukotriene B4 by human neutrophils: The role of microtubules
37. Immunosuppressive potential of antimalarials
38. Effectiveness of chloroquine and hydroxychloroquine in treating selected patients with sarcoidosis with neurological involvement
39. Blockage of amyloid induction by colchicine in an animal model
40. Selective regulation of cytokine secretion by hydroxychloroquine: Inhibition of interleukin 1 alpha (IL-1-a) and IL-6 in human monocytes and T cells
41. Pathogenesis and treatment of crystal-induced inflammation
42. Potentially amyloidogenic fragment of 50 kDa and intracellular processing of amyloid precursor protein in cells cultured under leupeptin
43. Co-localization of amyloid-associated proteins with amyloid b in rat soleus muscle in chloroquine-induced myopathy: A possible model for amyloid b formation in Alzheimer's disease
44. Colchicine analogues: Effect on amyloidogenesis in a murine model and, in vitro, on polymorphonuclear leukocytes
45. Reversal of the nephrotic syndrome by colchicine in amyloidosis of familial Mediterranean fever